NCT04066192View on ClinicalTrials.gov

Brexpiprazole in Alcohol Use Disorder

PHASE2RecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

October 30, 2020

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Alcohol Use Disorder
Interventions
DRUG

Brexpiprazole

Brexpiprazole will be used in .5mg, 1mg, 2mg, and 4mg doses as described in the study arms.

DRUG

Placebo

A medically inert placebo medication will be used as described in the study arms.

Trial Locations (1)

80045

RECRUITING

University of Colorado Anschutz Medical Campus, Aurora

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

University of Colorado, Denver

OTHER